Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

3D Biomatrix Wins Wall Street Journal Technology Innovation Award

Published: Friday, October 19, 2012
Last Updated: Friday, October 19, 2012
Bookmark and Share
3D Biomatrix, which develops and sells tools for drug discovery research and testing that mimic the human cellular environment, was selected as a winner in the Medicine and Biotech category of the 2012 Wall Street Journal Technology Innovation Awards.

3D Biomatrix, a leader in three-dimensional (3D) cell culture products, is pleased to announce today that the company was selected as runner-up in the Medicine and Biotech category in the highly prestigious 2012 Wall Street Journal Technology Innovation Awards. The company was chosen among 536 entries from over two dozen countries by an independent panel of judges, with only 7% of entries winning an award. 3D Biomatrix was recognized for the development of its Perfecta3D® Hanging Drop Plates, which are designed to allow researchers to perform cell culture in a 3D environment, as the human body is 3D, rather than a conventional 2D environment such as a flat Petri dish.

The Perfecta3D Hanging Drop Plates help researchers focused on cancer research and drug development, toxicology testing, and stem cell research to easily grow cells in small spherical 3D clusters called spheroids. Spheroids are one of the most well characterized models for 3D culture and screening due to their simplicity and similarity to human tissues, and until now, have been difficult to work with without large expense. The 3D Hanging Drop Plates make spheroid formation and testing easy and consistent in a familiar 96- and 384-well plate format.

Consistent and controllable 3D cell cultures allow pharmaceutical researchers to obtain more physiological data earlier in the testing process. “3D cell cultures can have a high impact on the pharmaceutical industry and human health by reducing the cost and time of taking a drug to market, and it is a great step forward to have this recognized by the business community,” said 3D Biomatrix CEO Laura Schrader. “We are thrilled to be recognized alongside other highly inventive companies in receiving this award for innovation from the Wall Street Journal.”

Recent news about 3D Biomatrix and information about the Perfecta3D Hanging Drop Plates can be found on the 3D Biomatrix website.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Ice Bucket Challenge Instrumental in Gene Discovery
Donations from the ALS Ice Bucket Chellenge allowed for the largest-ever study of inherited ALS, which identified a new ALS gene.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Cancer Related Immune Response Genes Uncovered
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer.
Deciphering Inactive X Chromosomes
Untangling the Barr body of inactive X chromosomes valuable for understanding chromosome structure and gene expression.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!